- Home
- TGLS vs PRCT Comparison
TGLS vs PRCT Comparison
Compare TGLS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGLS
- PRCT
- Stock Information
- Founded
- TGLS 1984
- PRCT 2009
- Country
- TGLS Colombia
- PRCT United States
- Employees
- TGLS N/A
- PRCT N/A
- Industry
- TGLS Electronic Components
- PRCT Medical Specialities
- Sector
- TGLS Consumer Discretionary
- PRCT Health Care
- Exchange
- TGLS Nasdaq
- PRCT Nasdaq
- Market Cap
- TGLS 3.9B
- PRCT 4.7B
- IPO Year
- TGLS 2012
- PRCT 2021
- Fundamental
- Price
- TGLS $69.22
- PRCT $62.25
- Analyst Decision
- TGLS Buy
- PRCT Strong Buy
- Analyst Count
- TGLS 5
- PRCT 7
- Target Price
- TGLS $75.40
- PRCT $97.86
- AVG Volume (30 Days)
- TGLS 274.4K
- PRCT 802.8K
- Earning Date
- TGLS 02-27-2025
- PRCT 02-25-2025
- Dividend Yield
- TGLS 0.87%
- PRCT N/A
- EPS Growth
- TGLS N/A
- PRCT N/A
- EPS
- TGLS 3.20
- PRCT N/A
- Revenue
- TGLS $845,211,000.00
- PRCT $199,843,000.00
- Revenue This Year
- TGLS $8.94
- PRCT $67.07
- Revenue Next Year
- TGLS $10.39
- PRCT $40.64
- P/E Ratio
- TGLS $21.65
- PRCT N/A
- Revenue Growth
- TGLS N/A
- PRCT 71.71
- 52 Week Low
- TGLS $40.94
- PRCT $45.20
- 52 Week High
- TGLS $86.99
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- TGLS 30.92
- PRCT 29.56
- Support Level
- TGLS $73.12
- PRCT $64.04
- Resistance Level
- TGLS $76.54
- PRCT $68.38
- Average True Range (ATR)
- TGLS 2.13
- PRCT 3.30
- MACD
- TGLS -0.73
- PRCT -0.15
- Stochastic Oscillator
- TGLS 0.98
- PRCT 1.14
About TGLS Tecnoglass Inc.
Tecnoglass Inc designs, manufactures, distributes, and markets architectural glass and windows. The company's products portfolio includes tempered, laminated, insulating and Solar Control Low-E glass. Its products are installed at hotels, residential buildings, commercial and corporate centers, airports and hospitals as floating facades, curtain walls, windows, doors, handrails, interior and dividers. Its majority of revenue is derived from the sale and installation of architectural glass and windows in the United States.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.